Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion dependent beta thalassaemia: a cross sectional study

Padmapani Padeniya, Dileepa Ediriweera, Arjuna De Silva, Madunil Niriella, Anuja Premawardhena
doi: https://doi.org/10.1101/2022.01.15.22269369

Article Information

doi 
https://doi.org/10.1101/2022.01.15.22269369
History 
  • January 16, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Padmapani Padeniya1,2,3,*,
  2. Dileepa Ediriweera1,
  3. Arjuna De Silva1,4,
  4. Madunil Niriella1 and
  5. Anuja Premawardhena1,3
  1. 1Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
  2. 2Hemas Hospital, Wattala, Sri Lanka
  3. 3Adolescent and Adult Thalassaemia Care Center (University Medical Unit), North Colombo Teaching Hospital, No. 10, Sirima Bandaranayake Mawatha, Kadawatha, Kadawatha, Sri Lanka
  4. 4Nawaloka Hospital PLC, Colombo, Sri Lanka
  1. ↵*Corresponding Author:
    Dr Padmapani Padeniya, Senior Lecturer, Department of Anatomy, Faculty of Medicine, University of Kelaniya, PO Box 6, Thalagolla Road, Ragama, Sri Lanka. Phone: + 94777334750, Email address: padmapani{at}kln.ac.lk
Back to top
Posted January 16, 2022.
Download PDF
Data/Code
Email
Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion dependent beta thalassaemia: a cross sectional study
Padmapani Padeniya, Dileepa Ediriweera, Arjuna De Silva, Madunil Niriella, Anuja Premawardhena
medRxiv 2022.01.15.22269369; doi: https://doi.org/10.1101/2022.01.15.22269369
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area